Mobidiag Ltd has announced the launch of Amplidiag™ C. difficile+027, a qualitative qPCR-based test performed from DNA extracted from stool in suspected cases of C. difficile infection (CDI). The test ...

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Wovenware, a nearshore provider of Artificial Intelligence (AI) and digital transformation solutions, announced today that it has been chosen as the software ...

Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation (CDI) has created a test to dramatically ...

Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent ...

Hackensack Meridian Health said Thursday that the Center for Discovery and Innovation (CDI) created a test to dramatically reduce the time it takes for diagnosing COVID-19. This is a major advance ...